These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2181 related items for PubMed ID: 17999272

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF, Miller A, Fine S.
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of methylphenidate on the quality of life in children with epilepsy and attention deficit hyperactivity disorder: and open-label study using an osmotic-controlled release oral delivery system.
    Yoo HK, Park S, Wang HR, Lee JS, Kim K, Paik KW, Yum MS, Ko TS.
    Epileptic Disord; 2009 Dec; 11(4):301-8. PubMed ID: 20007067
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Exploring the impact of once-daily OROS® methylphenidate (MPH) on symptoms and quality of life in children and adolescents with ADHD transitioning from immediate-release MPH.
    Kordon A, Stollhoff K, Niederkirchner K, Mattejat F, Rettig K, Schäuble B.
    Postgrad Med; 2011 Sep; 123(5):27-38. PubMed ID: 21904084
    [Abstract] [Full Text] [Related]

  • 18. Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder.
    Gorman EB, Klorman R, Thatcher JE, Borgstedt AD.
    J Am Acad Child Adolesc Psychiatry; 2006 Jul; 45(7):808-16. PubMed ID: 16832317
    [Abstract] [Full Text] [Related]

  • 19. The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study.
    van der Oord S, Prins PJ, Oosterlaan J, Emmelkamp PM.
    Clin Psychol Psychother; 2012 Jul; 19(3):270-8. PubMed ID: 21404369
    [Abstract] [Full Text] [Related]

  • 20. Sleep problems in children with attention-deficit/hyperactivity disorder: prevalence and the effect on the child and family.
    Sung V, Hiscock H, Sciberras E, Efron D.
    Arch Pediatr Adolesc Med; 2008 Apr; 162(4):336-42. PubMed ID: 18391142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 110.